advertiser banner advertiser banner advertiser banner
Digital Issues

Home >  News >  June, 2014

FDA Says More Decisions on Morcellation Coming

The agency will hold a public meeting in July.

Published: June 12, 2014

Will morcellation devices used to laparoscopically remove uterine fibroids be recalled or banned? The FDA is convening a meeting next month to take up the topic.

The agency issued an advisory in April, discouraging their use because the devices can spread cancerous tissue in women with undetected uterine sarcomas, a condition the agency says may affect as many as 1 in every 350 women.

However, proponents of morcellation say the proportion of women with undetected sarcomas is likely closer to 1 in 1,000; that the prognosis is already bleak for those women; and that for everyone else, the alternatives are typically much more dangerous and invasive.

The FDA's Medical Devices Advisory Committee will hold a public meeting on July 10 and 11 and plans to "make recommendations regarding the appropriate use, premarket testing, labeling, and other risk mitigations" for morcellators.

One stock analyst, Greg Chodaaczek of Sterne Agee, says the meeting is likely to result in a so-called black-box warning, saying he doesn't think there's enough data to warrant a recall or ban.

Jim Burger


Also in the News...

FDA Nixes Exparel as Nerve Block
Priest, Doc Say Brooklyn ASC Robbed Them Blind
Man Wins $1.8 Million After Surgeon Removes His Only Remaining Testicle
New Group Hopes to Rid ORs of Surgical Smoke
Tech Claims Hospital Discriminated Against Her After She Started Wearing Hearing Aids
Court Says No to Office-Based Surgery Site's Demand for Facility Fees
Court Backs Hospital's Firing of Employee Who Refused to Work With Difficult Doc

 
Have an account? Please log in:
Email Address:
  Remember my login on this computer

DID YOU SEE THIS?
General Anesthesia

This CO2 Absorbent Works Better and Saves You Money

advertiser banner

Other Articles That May Interest You

Medtronic Settles 950 Patients' Infuse Lawsuits

Fatal Cataract Sedation Results in $2.1M Settlement

Patient "inexplicably left alone" and unmonitored before surgery.

Legal Update: Is It Safe to Say You're Sorry?

Communicating adverse outcomes can be complicated.